(Q41673554)

English

Chronic Treatment With P2 -Purinergic Receptor Agonists Induces Phenotypic Modulation of the HL-60 and U937 Human Myelogenous Leukemia Cell Lines

scientific article published on August 1, 1991

Statements

Chronic Treatment With P2 -Purinergic Receptor Agonists Induces Phenotypic Modulation of the HL-60 and U937 Human Myelogenous Leukemia Cell Lines (English)
Chronic treatment with P2-purinergic receptor agonists induces phenotypic modulation of the HL-60 and U937 human myelogenous leukemia cell lines (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit